跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
辅舒酮 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Fluticasone Propionate Nebuliser Suspension
Approved
化学药品
Fluticasone Propionate Nebuliser Suspension
Unknown
🇨🇳 National Medical Products Administration
Approval Date
Jan 11, 2022
Approval ID
8JDUzD5KTr5
Company
Unknown
Type
化学药品
Approval Details
Approval Id
8JDUzD5KTr5
Approval Number
国药准字HJ20170361
Generic Name
丙酸氟替卡松雾化吸入用混悬液
Generic Name En
Fluticasone Propionate Nebuliser Suspension
Brand Name
辅舒酮
Drug Type
化学药品
Dosage Form
雾化吸入用混悬液
Strength
2ml:0.5mg
Reg Date
2022-01-11
Expired Date
2027-01-10
Production Company Name
Glaxosmithkline Australia Pty Ltd.
Production Company Detail Path
/organization/glaxosmithkline-australia-pty-ltd-australia
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 11, 2022
Approval ID
8JDUzD5KTr5
Type
化学药品
Back to NMPA Approvals